Intervención en trastorno por consumo de cannabis sintético: un estudio de caso.

• Autores: Abel Baquero Escribano, Juan Robledillo Martín, Isabel Vilimelis Cabedo, José Miguel Sanlucas Peréz, Miguel Monfort Montoliu, Mihaela Dalae
• Localización: Informació psicològica, ISSN 0214-347X, Nº. 117 (Enero-junio: Adicciones), 2019, págs. 88-98
• Idioma: español
• Títulos paralelos:
  • Intervention in synthetic cannabis use disorder: a case study.
• Enlaces
  • Texto completo (pdf)
• Resumen
  • español

    Introducción: El consumo de cannabis sintético es una creciente realidad dentro de la atención a los trastornos por consumo de nuevas sustancias psicoactivas; la dificultad en su detección, bajo coste y el fácil acceso a la sustancia guardarían relación con este incremento del consumo. Los efectos, tratamientos y posibles consecuencias del uso de esta sustancia son objeto de estudio. Presentación de caso: Comentamos el caso clínico e intervención de varón diagnosticado con trastorno por consumo de cannabis sintético en el contexto de un tratamiento residencial en comunidad terapéutica. Con la intervención diseñada el paciente mantiene la abstinencia y una incipiente funcionalidad autónoma facilitando el alta tras cumplimiento del programa. Conclusiones: La intervención en pacientes consumidores de cannabis sintético es un contexto terapéutico en el que se está comenzando a investigar, siendo necesario diseñar nuevas propuestas de atención, detectando los efectos y farmacodinámica de la sustancia.

  • English

    Introduction: The consumption of synthetic cannabis is a growing reality within the attention to the disorders by consumption of new psychoactive substances; the difficulty in its detection, low cost and easy access to the substance would be related to this increase in consumption. The effects, treatments and possible consequences of the use of this substance are subject of study.Case presentation: We discuss the clinical case and intervention of a male diagnosed with a synthetic cannabis use disorder in the context of a residential treatment in a therapeutic community.

    With the intervention designed the patient maintains abstinence and an incipient autonomous functionality facilitating discharge after compliance with the program. Conclusions: The intervention in patients consuming synthetic cannabis is a therapeutic context in which it is beginning to investigate, being necessary to design new care proposals, detecting the effects and pharmacodynamics of the substance.

• Referencias bibliográficas
  • Abuse, S. (2013). Mental Health Services Administration, Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department...
  • American Psychiatric Association. (2013). Manual Diagnóstico y Estadístico de los Trastornos Mentales (DSM –5®), 5º. Ed. Arlington, VA, Asociación...
  • Baquero, A., Orenga, G. ., Carratalá, S., Arnau, F., Meca, S., & Haro, G. (2016). Consumo de krokodil por vía oral en España: A propósito...
  • Beck, A. y Freeman, A. (1995) Terapia cognitiva de los trastornos de personalidad. Buenos Aires: Paidós ediciones.
  • Blevins, C. E., Banes, K. E., Stephens, R. S., Walker, D. D., & Roffman, R. A. (2016). Change in motives among frequent cannabis-using...
  • Bonar, E. E., Ashrafioun, L., & Ilgen, M. A. (2014). Synthetic cannabinoid use among patients in residential substance use disorder treatment:...
  • Castellanos, D., Singh, S., Thornton, G., Avila, M., & Moreno, A. (2011). Synthetic cannabinoid use: a case series of adolescents. Journal...
  • Cooper, Z. D. (2016). Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal. Current Psychiatry Reports....
  • Curtis, B., Alanis‐Hirsch, K., Kaynak, Ö., Cacciola, J., Meyers, K., & McLellan, A. T. (2015). Using web searches to track interest...
  • Danovitch, I., & Gorelick, D. A. (2012). State of the art treatments for cannabis dependence. Psychiatric Clinics, 35(2), 309-326.
  • Davis, M. L., Powers, M. B., Handelsman, P., Medina, J. L., Zvolensky, M., & Smits, J. A. (2015). Behavioral therapies for treatment-seeking...
  • Dennis, M., Titus, J. C., Diamond, G., Donaldson, J., Godley, S. H., Tims, F. M., … Scott, C. K. (2002). The Cannabis Youth Treatment (CYT)...
  • Dillon, P., & Copeland, J. (2012). Synthetic cannabinoids: the Australian experience. Bulletin Series, 13(March), 1-10.
  • Folstein, M.F., Folstein, S.E., & McHugh P.R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients...
  • Forrester, M. B. (2012). Adolescent synthetic cannabinoid exposures reported to Texas poison centers. Pediatric emergency care, 28(10), 985-989.
  • Gates, P. J., Sabioni, P., Copeland, J., Le Foll, B., & Gowing, L. (2016). Psychosocial interventions for cannabis use disorder. Cochrane...
  • Higgins, S. T., Silverman, K., & Heil, S. H. (Eds.). (2008). Contingency management in substance abuse treatment. New York, NY, US: Guilford...
  • Hurst, D., Loeffler, G., & McLay, R. (2011). Psychosis associated with synthetic cannabinoid agonists: a case series. American Journal...
  • Johnson, L. A., Johnson, R. L., & Alfonzo, C. (2011). Spice: a legal marijuana equivalent. Military medicine, 176(6), 718-720.
  • Keyes, K. M., Rutherford, C., Hamilton, A., & Palamar, J. J. (2016). Age, period, and cohort effects in synthetic cannabinoid use among...
  • Lipsky, M. S., & Sharp, L. K. (2001). From idea to market: the drug approval process. The Journal of the American Board of Family Practice...
  • Lobo, A., Ezquerra, J., Gómez, F. B., Sala, J. M., & Seva, A. D. (1979). Cognocitive mini-test (a simple practical test to detect intellectual...
  • Miller, W. R. (1983). Motivational interviewing with problem drinkers. Behavioural and Cognitive Psychotherapy, 11(2), 147-172.
  • Mitchell, J. T., Sweitzer, M. M., Tunno, A. M., Kollins, S. H., & Joseph McClernon, F. (2016). “I use weed for my ADHD”: A qualitative...
  • Nordstrom, B. R., & Levin, F. R. (2007). Treatment of cannabis use disorders: a review of the literature. American Journal on Addictions,...
  • Ochoa-Mangado, E., Madoz-Gúrpide, A., Villacieros-Durbán, I., Llama-Sierra, P., & Sancho-Acero, J. L. (2010). Trastorno por déficit de...
  • Pinto, R. J., Fernandes, A. I., Mesquita, C., & Maia, Â. C. (2015). Childhood adversity among institutionalized male juvenile offenders...
  • Poudevida J. S., Camí M. J., Farré A. M., y Roset A. P. (2003). Construcción de un cuestionario para la valoración de los efectos subjetivos...
  • Prochaska, J.O. and DiClemente, C.C. (1984) The Transtheoretical Approach: Towards a Systematic Eclectic Framework. Dow Jones Irwin, Homewood.
  • Ralphs, R., Williams, L., Askew, R., & Norton, A. (2017). Adding Spice to the Porridge1: The development of a synthetic cannabinoid market...
  • Richardson, J. B., Vil, C. S., Wish, E., & Cooper, C. (2016). “On papers”: perceptions of synthetic cannabinoid use among black males...
  • Salani, D. A., & Zdanowicz, M. M. (2015). Synthetic cannabinoids: the dangers of spicing it up. Journal of psychosocial nursing and mental...
  • Schettino, J., Leuschner, F., Kasten, L., & Tossman, P. (2015). Treatment of cannabis-related disorders in Europe. European monitoring...
  • Smith, D. L., & Roberts, C. (2014). Synthetic marijuana use and development of catatonia in a 17-year-old male. Minnesota medicine, 97(5),...
  • Sun, X., & Dey, S. K. (2014). Synthetic cannabinoids and potential reproductive consequences. Life sciences, 97(1), 72-77.
  • Tait, R. J., Caldicott, D., Mountain, D., Hill, S. L., & Lenton, S. (2016). A systematic review of adverse events arising from the use...
  • Thatcher, D. L., & Clark, D. B. (2006). Adolescent alcohol abuse and dependence: development, diagnosis, treatment and outcomes. Current...
  • Vernon, J. A., Golec, J. H., & Dimasi, J. A. (2010). Drug development costs when financial risk is measured using the Fama-French three-factor...
  • Werse, B., & Morgenstern, C. (2012). How to handle legal highs? Findings from a German online survey and considerations on drug policy...
  • Williams, J., & Bretteville-Jensen, A. L. (2014). Does liberalizing cannabis laws increase cannabis use?. Journal of health economics,...
  • Winstock, A. R. and Barratt, M. J. (2013) The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations...